Background
Company Logo

KINETAI Drug Design Platform

Integrating advanced artificial intelligence technology to accelerate drug development

ADME/T Druggability
Drug metabolism and toxicity prediction to optimize pharmacokinetic properties of compounds. Analyze absorption, distribution, metabolism, excretion, and toxicity profiles to support lead optimization and candidate selection.
Affinity Prediction
Coming Soon
Predict binding affinity between small molecules and protein targets to accelerate drug discovery. KINET platform employs multimodal deep learning architectures that integrate structural information and biophysical features to precisely evaluate binding conformations and affinity coefficients for novel compounds.
Molecular Generation
Coming Soon
AI-based molecular design and generation to create novel compounds with specific properties. KINET platform employs generative models to explore chemical space and propose structures with optimal target activity and drug-like properties.
LexFold
Coming Soon
Complex structure prediction and analysis to provide structural basis for targeted drug design. Utilize our advanced protein folding algorithms to model protein structures and identify potential binding sites for rational drug design.

Our Technical Advantages

Advanced AI Algorithms

Leveraging advanced deep learning and molecular simulation technologies to deliver accurate support for drug design

Comprehensive Innovation

Guiding the entire journey of drug discovery, from molecular design to ADME/T prediction

User-Friendly Interface

An intuitive workflow that transforms complex process into smooth efficiency

Demonstrated Validation

Rigorously tested models providing consistently reliable predictions with high accuracy across diverse chemical space